Physician profile
Samuel S Wu
NPI 1184845760
$741.29
in general payments reported to CMS, 2019-2025
18 companies · $59.91 in 2025
The $59.91 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $77.90 · 2021: $139 · 2022: $149 · 2024: $120 · 2025: $59.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $150.16 | 2019-2022 | |
| Astellas Pharma US INC | $128.47 | 2019-2021 | |
| Biosense Webster, INC. | $100.99 | 2024 | Carto 3 |
| Amarin Pharma, INC. | $45.61 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $43.61 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $41.96 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $38.76 | 2022-2025 | Uptravi, Opsumit |
| Esperion Therapeutics, INC. | $24.90 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.52 | 2019 | |
| Heartflow, INC. | $21.36 | 2025 | |
| Atricure, INC. | $20.26 | 2019 | |
| Cvrx, INC. | $18.92 | 2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $17.26 | 2025 | Inspiris Resilia Aortic Valve |
| Elutia, INC. | $14.51 | 2022 | |
| Gilead Sciences, INC. | $13.88 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.50 | 2019 | |
| Medtronic Vascular, INC. | $13.38 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.